Literature DB >> 15577090

The role of magnesium in traumatic brain injury.

Corinna van den Heuvel1, Robert Vink.   

Abstract

In Japan, over 5,000 deaths per year are a result of traumatic brain injury (TBI) with most being due to motor vehicle accidents. Survivors of TBI number into the hundreds of thousands and are often left with debilitating neurological deficits. Recently it has been identified that much of the brain damage after TBI develops over time with the primary injury initiating a secondary injury cascade made up of deleterious pathophysiological and biochemical reactions. The delayed development of secondary injury creates an opportunity for therapeutic intervention and considerable effort is being directed toward identifying the secondary injury factors and developing interventions that may potentially prevent their actions. Several secondary injury factors have been identified including oxidative stress, changes in blood flow, neurotransmitters and ionic changes, oedema and energy failure. Of these, Mg(2+) decline has been identified as playing a crucial role in the secondary injury process, in part because of its central role in the regulation of a large number of other known injury factors. This brief review will summarize the experimental evidence supporting a critical role of Mg(2+) in the pathophysiology of TBI, and will examine the use of magnesium salts as a therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15577090     DOI: CliCa040811871192

Source DB:  PubMed          Journal:  Clin Calcium        ISSN: 0917-5857


  8 in total

Review 1.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

2.  Pyridoxine administration improves behavioral and anatomical outcome after unilateral contusion injury in the rat.

Authors:  Nicholas J Kuypers; Michael R Hoane
Journal:  J Neurotrauma       Date:  2010-07       Impact factor: 5.269

3.  Type 2 diabetes induced oxidative brain injury involves altered cerebellar neuronal integrity and elemental distribution, and exacerbated Nrf2 expression: therapeutic potential of raffia palm (Raphia hookeri) wine.

Authors:  Ochuko L Erukainure; Omamuyovwi M Ijomone; Olakunle Sanni; Michael Aschner; Md Shahidul Islam
Journal:  Metab Brain Dis       Date:  2019-06-14       Impact factor: 3.584

Review 4.  Use of magnesium in traumatic brain injury.

Authors:  Ananda P Sen; Anil Gulati
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

5.  Magnesium therapy improves outcome in Streptococcus pneumoniae meningitis by altering pneumolysin pore formation.

Authors:  Sabrina Hupp; Sandra Ribes; Jana Seele; Carolin Bischoff; Christina Förtsch; Elke Maier; Roland Benz; Timothy J Mitchell; Roland Nau; Asparouh I Iliev
Journal:  Br J Pharmacol       Date:  2017-10-19       Impact factor: 8.739

Review 6.  Emerging treatments for traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Expert Opin Emerg Drugs       Date:  2009-03       Impact factor: 4.191

Review 7.  Neuro-Inflammation Modulation and Post-Traumatic Brain Injury Lesions: From Bench to Bed-Side.

Authors:  Alice Jacquens; Edward J Needham; Elisa R Zanier; Vincent Degos; Pierre Gressens; David Menon
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

8.  Serum Magnesium as a Marker of Neurological Outcome in Severe Traumatic Brain Injury Patients.

Authors:  Raghavendra Nayak; Sanjeev Attry; Samarendra Nath Ghosh
Journal:  Asian J Neurosurg       Date:  2018 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.